Comment
doi: 10.1016/S0140-6736(18)31884-1.
Epub 2018 Aug 27.
Aspirin-still the GLOBAL LEADER in antiplatelet therapy
Affiliations
- PMID: 30166072
- DOI: 10.1016/S0140-6736(18)31884-1
Item in Clipboard
Comment
Aspirin-still the GLOBAL LEADER in antiplatelet therapy
Lancet.
.
No abstract available
Comment on
-
Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trial.Lancet. 2018 Sep 15;392(10151):940-949. doi: 10.1016/S0140-6736(18)31858-0. Epub 2018 Aug 27. Lancet. 2018. PMID: 30166073 Clinical Trial.
Similar articles
-
Newer antiplatelet therapies in stroke prevention.Aust Fam Physician. 2001 Feb;30(2):129-34. Aust Fam Physician. 2001. PMID: 11280112
-
New modalities and aspects of antiplatelet therapy for stroke prevention.Cerebrovasc Dis. 2006;21 Suppl 1:7-16. doi: 10.1159/000090357. Epub 2006 Feb 13. Cerebrovasc Dis. 2006. PMID: 16479097
-
Antiplatelet therapy in the prevention of ischaemic stroke.Nouv Rev Fr Hematol (1978). 1994 Jun;36(3):213-28. Nouv Rev Fr Hematol (1978). 1994. PMID: 7971242 Review.
-
Association of recurrent cerebral infarction with adenosine diphosphate- and collagen-induced platelet aggregation in patients treated with ticlopidine and/or aspirin.J Stroke Cerebrovasc Dis. 2011 Jul-Aug;20(4):319-23. doi: 10.1016/j.jstrokecerebrovasdis.2010.01.013. Epub 2010 Jul 15. J Stroke Cerebrovasc Dis. 2011. PMID: 20634093
-
Indications for dual antiplatelet therapy with aspirin and clopidogrel: evidence-based recommendations for use.Ann Pharmacother. 2008 Apr;42(4):550-7. doi: 10.1345/aph.1K433. Epub 2008 Mar 4. Ann Pharmacother. 2008. PMID: 18319394 Review.
Cited by
-
Pharmacodynamic Comparison of Ticagrelor Monotherapy Versus Ticagrelor and Aspirin in Patients After Percutaneous Coronary Intervention: The TEMPLATE (Ticagrelor Monotherapy and Platelet Reactivity) Randomized Controlled Trial.J Am Heart Assoc. 2020 Dec 15;9(24):e016495. doi: 10.1161/JAHA.120.016495. Epub 2020 Dec 11. J Am Heart Assoc. 2020. PMID: 33305660 Free PMC article. Clinical Trial.
-
Rationale, design and baseline characteristics of the effect of ticagrelor on health outcomes in diabetes mellitus patients Intervention study.Clin Cardiol. 2019 May;42(5):498-505. doi: 10.1002/clc.23164. Epub 2019 Apr 9. Clin Cardiol. 2019. PMID: 30788847 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
